
|Articles|October 24, 2012
Metabolic syndrome raises prostate Ca death risk
Components of metabolic syndrome have been jointly linked with an increased risk of dying from prostate cancer, according to a recent study.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: Prostate Cancer Screening in the Transgender Population, with Farnoosh Nik-Ahd, MD
2
Jesse Mills, MD, outlines the pitfalls of bundled TRT treatments
3
Rectal spacers move beyond toxicity reduction in prostate radiation
4
Simplifying stent removal coding: Understanding 52310 vs 52315
5


















